iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market

iX Biopharma Ltd. (42C) Cash flow

3 Followers

iX Biopharma Ltd. Cash Flow

SG:42C's free cash flow for Q4 2021 was S$―. For the 2021 fiscal year, SG:42C's free cash flow was decreased by S$409.00K and operating cash flow was S$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 21Jun 20Jun 19Jun 18Jun 17
Operating Cash Flow
S$ -4.22MS$ -8.35MS$ -8.32MS$ -13.90MS$ -8.36MS$ -4.16M
Investing Cash Flow
S$ -408.00KS$ -507.00KS$ -994.00KS$ 9.74MS$ -1.19MS$ -1.12M
Financing Cash Flow
S$ -400.00KS$ 10.02MS$ -826.00KS$ -1.58MS$ -248.00KS$ 4.59M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
S$ 22.20MS$ 5.58MS$ 4.47MS$ 14.71MS$ 20.67MS$ 30.69M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-S$ 10.18M--S$ 0.00S$ 4.70M
Issuance Of Debt
---S$ 0.00S$ 308.00KS$ 529.00K
Repayment Of Debt
S$ -281.00KS$ -226.00KS$ -213.00KS$ -565.00KS$ -289.00KS$ -263.00K
Free Cash Flow
S$ -4.62MS$ -8.90MS$ -9.31MS$ -15.59MS$ -9.55MS$ -5.28M
Domestic Sales
------
Foreign Sales
------
Currency in SGD

iX Biopharma Ltd. Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis